Myozyme and oxygen saturation decreased 
Myozyme and oxygen saturation decreased Patient Reports February 13, 2012
Myozyme Side Effects Report #6139001-4
Myozyme side effect was reported by a Physician from ITALY on Mar 19, 2009. Male patient, 84 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: oxygen saturation decreased, respiratory disorder. Myozyme dosage: 20 MG/KG BW, INTRAVENOUS. Patient was hospitalized. Patient died on 03/01/2009.
Myozyme Side Effects Report #5579303-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2007. Female patient, 70 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: muscle disorder
, oxygen saturation decreased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 12/13/2007.Myozyme Side Effects Report #5753661-9
Myozyme side effect was reported by a Physician from UNITED STATES on May 14, 2008. Female patient, 66 years of age, weighting 191.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, feeling hot, hypersensitivity, oxygen saturation decreased, respiratory distress. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5753664-4
Myozyme side effect was reported by a Physician from UNITED STATES on May 14, 2008. Female patient, 66 years of age, weighting 191.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, feeling hot, hypersensitivity, oxygen saturation decreased, respiratory distress. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5325824-8
Myozyme side effect was reported by a Physician from GERMANY on Apr 26, 2007. Female patient, 58 years of age, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, erythema, oxygen saturation decreased, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5248067-5
Myozyme side effect was reported by a Physician from GERMANY on Feb 08, 2007. Female patient, 55 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, dyspnoea, infusion related reaction, oxygen saturation decreased, respiratory distress. Myozyme dosage: 1200 MG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5170229-6
Myozyme side effect was reported by a Physician from GERMANY on Nov 21, 2006. Female patient, 55 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, infusion related reaction, oxygen saturation decreased, respiratory distress. Myozyme dosage: 1200 MG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5336329-2
Myozyme side effect was reported by a Physician from UNITED STATES on May 09, 2007. Female patient, 33 years of age, weighting 160.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness
, dyspnoea, flushing, headache , hypersensitivity, nausea , oxygen saturation decreased, peak expiratory flow rate decreased. Myozyme dosage: 10 MG/KG QWK IV. During the same period patient was treated with PREDNISONE, SYNTHROID, NAPROXEN, HYDROCODONE BITARTRATE, HYDROCORTISONE. Patient recovered.Myozyme Side Effects Report #5506909-X
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2007. Female patient, child 3 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: hyperparathyroidism, infusion related reaction, muscular weakness, oxygen saturation decreased, urinary tract infection
. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5625286-7
Myozyme side effect was reported by a Physician from ARGENTINA on Jan 30, 2008. Female patient, child 3 years of age, weighting 35.27 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: atelectasis, bronchospasm, device failure, infusion related reaction, oxygen saturation decreased, pneumonia
, pyrexia, respiratory distress. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLUTICASONE PROPIONATE, FEROUS SULPHATE, SALBUTAMOL, CARNITENE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5483158-5
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 25, 2007. Female patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, infusion related reaction, mechanical ventilation, myocardial ischaemia, nausea , oxygen saturation decreased, regurgitation, respiratory failure. Myozyme dosage: unknown. Patient recovered.Myozyme Side Effects Report #5713823-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5725882-2
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, glycogen storage disease type ii, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #6081259-4
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Female patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac disorder, cyanosis, oxygen saturation decreased, respiratory arrest. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 02/02/2009.
Myozyme Side Effects Report #5339799-9
Myozyme side effect was reported by a Physician from UNITED STATES on May 11, 2007. Male patient, child 1 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, bronchospasm, disease recurrence, hypotension, oxygen saturation decreased, wheezing. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5460687-1
Myozyme side effect was reported by a Physician from BRAZIL on Sept 04, 2007. Male patient, child 1 years of age, weighting 21.23 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: crying, cyanosis, lethargy, nausea
, oxygen saturation decreased, pallor, palmar erythema, rash , tachycardia. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with PROPRANOLOL, CAPTOPRIL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5285761-4
Myozyme side effect was reported by a Pharmacist from UNITED STATES on Dec 12, 2006. Female patient, weighting 12.57 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: nasal flaring, oxygen saturation decreased. Myozyme dosage: 150 MG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5255199-4
Myozyme side effect was reported by a Physician from ITALY on Feb 14, 2007. Female patient, weighting 14.33 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: central line infection, cyanosis, hypotension, oxygen saturation decreased, viral infection
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5293817-5
Myozyme side effect was reported by a Physician from ITALY on Mar 22, 2007. Female patient, weighting 14.33 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: central line infection, cyanosis, hypotension, infusion related reaction, oxygen saturation decreased. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5362841-6
Myozyme side effect was reported by a Physician from UNITED STATES on June 01, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: base excess increased, blood bicarbonate increased, muscle disorder
, oxygen saturation decreased, pyrexia, respiratory failure, wheezing. Myozyme dosage: 10 MG/KG QWK IV. During the same period patient was treated with DIGOXIN. Patient died on 06/07/2007.Myozyme Side Effects Report #5106859-7
Myozyme side effect was reported by a Physician from BRAZIL on Aug 31, 2006. Male patient, weighting 19.82 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, complement factor increased, cyanosis, erythema, infusion related reaction, lethargy, oxygen saturation decreased, pallor, rash
. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with PROPRANOLOL, CAPTOPRIL, LASIX. Patient recovered.Myozyme Side Effects Report #5383665-X
Myozyme side effect was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, weighting 16.76 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure acute, chest x-ray abnormal, condition aggravated, dilatation ventricular, heart rate decreased, oxygen saturation decreased, rash erythematous. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with UNASYN, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5404196-4
Myozyme side effect was reported by a Physician from UNITED STATES on July 17, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood gases abnormal, cardio-respiratory arrest, oxygen saturation decreased, pneumonia aspiration, respiratory distress, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient died on 07/19/2007.
Myozyme Side Effects Report #5614282-1
Myozyme side effect was reported by a Physician from GERMANY on Jan 29, 2008. Male patient, weighting 12.79 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, bradycardia, failure to thrive, no therapeutic response, oxygen saturation decreased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, SPIRONOLACTONE, ALANINE. Patient recovered.
Myozyme Side Effects Report #5714330-4
Myozyme side effect was reported by a Physician from ISRAEL on Apr 10, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5724272-6
Myozyme side effect was reported by a Physician from GERMANY on Apr 19, 2008. Male patient, weighting 12.79 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, bradycardia, developmental delay, failure to thrive, muscle disorder
, no therapeutic response, oxygen saturation decreased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, SPIRONOLACTONE, ALANINE. Patient recovered.Myozyme Side Effects Report #5724720-1
Myozyme side effect was reported by a Health Professional from ISRAEL on Apr 18, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5747234-1
Myozyme side effect was reported by a Physician from ISRAEL on Apr 27, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5753890-4
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on May 16, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5754824-9
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on May 12, 2008. Male patient, weighting 19.84 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, body temperature decreased, disease recurrence, heart rate increased, irritability, oxygen saturation decreased, respiratory rate increased, tachypnoea. Myozyme dosage: 10 MG/KG, QW, INTRAVENOUS, 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with VENA, PREDNISOLONE. Patient recovered.
Myozyme Side Effects Report #5795978-8
Myozyme side effect was reported by a Health Professional from UNITED STATES on June 20, 2008. Female patient, weighting 7.94 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: catheter placement, diarrhoea, oxygen saturation decreased, vomiting. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5827019-8
Myozyme side effect was reported by a Physician from JAPAN on July 09, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #5828424-6
Myozyme side effect was reported by a Physician from JAPAN on July 23, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, inguinal hernia repair, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #5829500-4
Myozyme side effect was reported by a Physician from UNITED STATES on July 16, 2008. Female patient, weighting 7.94 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, catheter placement, diarrhoea, oxygen saturation decreased, vomiting. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5842948-7
Myozyme side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: erythema, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSTULFATE. Patient recovered.Myozyme Side Effects Report #5849977-8
Myozyme side effect was reported by a Physician from UNITED STATES on Aug 04, 2008. Male patient, weighting 20.06 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: hyperhidrosis, infusion related reaction, oxygen saturation decreased, pallor, petechiae, rash
, respiratory distress, retching, tachycardia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with RANITIDINE, PREDNISONE, CETIRIZINE, XOPENEX, PULMICORT, IPRATROPIUM BR, METOCLORPAMIDE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5850383-0
Myozyme side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, weighting 20.06 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: grunting, hyperhidrosis, infusion related reaction, oxygen saturation decreased, pallor, petechiae, rash
, respiratory distress, retching. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with RANITIDINE, PREDNISONE, CETIRIZINE, XOPENEX, PULMICORT, IPRATROPIUM BR, METOCLOPRAMIDE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5875731-7
Myozyme side effect was reported by a Physician from UNITED STATES on Aug 27, 2008. Male patient, weighting 20.06 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, blood immunoglobulin g increased, blood pressure decreased, crying, hyperhidrosis, infusion related reaction, nasal congestion, oxygen saturation decreased, pallor. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with RANITIDINE, PREDNISONE, CETIRIZINE, XOPENEX, PULMICORT, IPRATROPIUM BR, METOCLOPRAMIDE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5887199-5
Myozyme side effect was reported by a Physician from JAPAN on Sept 02, 2008. Male patient, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, erythema, infusion related reaction, oxygen saturation decreased, rash
. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ATARAX, ENALAPRIL MALEATE, ANTIBIOTICS, FUROSEMIDE, ASPIRIN, PICOSULPHATE. Patient recovered.Myozyme Side Effects Report #5917212-8
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, cough, disease progression, hypoxia, irritability, nasopharyngitis, oxygen saturation decreased, rales. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5919121-7
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 01, 2008. Male patient, weighting 19.84 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, body temperature decreased, cough, heart rate increased, hypersensitivity, irritability, oxygen saturation decreased, rhinorrhoea, tachypnoea. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS; 15 MG/KG, QW, INTRAVENOUS; 10MG/KG, QW, INTRAVENOUS;. During the same period patient was treated with VENA, PREDNISONE. Patient recovered.
Myozyme Side Effects Report #5930343-1
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 17, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5945822-0
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 24, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #6133166-6
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 11, 2009. Female patient, weighting 7.94 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, central venous catheterisation, oxygen saturation decreased, post procedural complication, post procedural diarrhoea, procedural vomiting. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.